Patent ID: 11878987
Assignee: BEIJING INNOCARE PHARMA TECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 4:
5. The compound according to claim 1, or an isomer, prodrug, solvate, stable isotopic derivative or pharmaceutically acceptable salt thereof,
wherein:
L1 is NR6CON(R7)—, of which NR6 is connected with the nitrogen-containing heteroaryl substituted by R1, R2, and R3;
L2 is selected from C1-C4 alkylene and C2-C4 alkenylene, wherein the alkylene and alkenylene can be optionally substituted by one or more G1;
L3 is selected from a single bond and —O—;
R1, R2, and R3 are each independently selected from hydrogen, halogen and C1-C4 alkyl, wherein the alkyl is optionally substituted by one or more substituents selected from halogen;
R4 is selected from hydrogen, halogen, —NR8R9, and —OR10;
R5 is selected from hydrogen, halogen, C1-C4 alkyl and C3-C6 cyclyl;
R6 and R7 are each independently selected from hydrogen, C1-C4 alkyl, and C1-C4 haloalkyl;
G1 is selected from halogen, C1-C4 alkyl, —NR8R9, and —OR10, wherein the alkyl is optionally substituted by one or more substituents selected from halogen, —NR11R12, and —OR16; and
R8, R9, R10, R11, R12 and R16 are each independently selected from hydrogen, C1-C4 alkyl, and C1-C4 haloalkyl;
wherein the following compounds (1) to (5) are excluded:,